Medindia

X

Study: Biomarkers Predict Time to Ovarian Cancer Recurrence

by Rukmani Krishna on  August 20, 2013 at 12:42 AM Cancer News   - G J E 4
Often, ovarian cancer remains undetected until it is at an advanced stage. Many patients are at risk of tumor recurrence, despite positive responses to initial treatment.
 Study: Biomarkers Predict Time to Ovarian Cancer Recurrence
Study: Biomarkers Predict Time to Ovarian Cancer Recurrence
Advertisement

A multitude of genetic markers have been implicated in ovarian cancer prognosis. However, the genetic testing required is not practical or affordable in a clinical setting. In this issue of the Journal of Clinical Investigation, Roel Verchaak and colleagues at the MD Anderson Cancer Center identify protein biomarkers that are predictive for time of ovarian cancer recurrence and develop a PRotein-driven index of OVARian cancer (PROVAR). Using PROVAR, the authors were able to discriminate between patients with high and low risk of cancer recurrence, as well as short-term and long-term survival prognosis. In combination with genetic diagnosis, analysis of protein biomarkers may be useful in predicting outcome and determining a treatment plan for ovarian cancer patients.

Advertisement
Source: Eurekalert
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All